Bile acid-mediated induction of cyclooxygenase-2 and Mcl-1 in hepatic stellate cells

Biochemical and Biophysical Research Communications

Volumn 342, Issue 4, 2006, Pages 1108-1113

  Kim, Kang Mo ^a   Yoon, Jung Hwan ^a   Gwak, Geum Youn ^a   Kim, Won ^a   Hee Lee, Sung ^a   June Jang, Ja ^a   Lee, Hyo Suk ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Apoptosis; Bile acid; Cyclooxygenase 2; Hepatic stellate cell; Mcl 1

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BILE ACID; CELECOXIB; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN MCL 1; PROTEIN P42; PROTEIN P44; RAF PROTEIN; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; BILE ACID METABOLISM; CELL FUNCTION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; HUMAN; HUMAN CELL; LIVER CELL; LIVER DISEASE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; RAT; STELLATE CELL;

ANIMALS; APOPTOSIS; CELL LINE; CELL SURVIVAL; CHENODEOXYCHOLIC ACID; CYCLOOXYGENASE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; HEPATOCYTES; HUMANS; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 33644883884     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.02.072     Document Type: Article

References (34)

1. S.L. Friedman Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies N. Engl. J. Med. 328 1993 1828 1835
2. R. Bataller, and D.A. Brenner Hepatic stellate cells as a target for the treatment of liver fibrosis Semin. Liver Dis. 21 2001 437 451
3. J. Wu, and M.A. Zern Hepatic stellate cells: a target for the treatment of liver fibrosis J. Gastroenterol. 35 2000 665 672
4. P. Taimr, H. Higuchi, E. Kocova, R.A. Rippe, S. Friedman, and G.J. Gores Activated stellate cells express the TRAIL receptor-2/death receptor-5 and undergo TRAIL-mediated apoptosis Hepatology 37 2003 87 95
5. D.L. Schmucker, M. Ohta, S. Kanai, Y. Sato, and K. Kitani Hepatic injury induced by bile salts: correlation between biochemical and morphological events Hepatology 12 1990 1216 1221
6. W.A. Faubion, M.E. Guicciardi, H. Miyoshi, S.F. Bronk, P.J. Roberts, P.A. Svingen, S.H. Kaufmann, and G.J. Gores Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas J. Clin. Invest. 103 1999 137 145
7. H. Higuchi, S.F. Bronk, M. Taniai, A. Canbay, and G.J. Gores Cholestasis increases tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-R2/DR5 expression and sensitizes the liver to TRAIL-mediated cytotoxicity J. Pharmacol. Exp. Ther. 303 2002 461 467
8. H. Higuchi, J.H. Yoon, A. Grambihler, N. Werneburg, S.F. Bronk, and G.J. Gores Bile acids stimulate cFLIP phosphorylation enhancing TRAIL-mediated apoptosis J. Biol. Chem. 287 2003 454 461
9. M.K. Li, and J.M. Crawford The pathology of cholestasis Semin. Liver Dis. 24 2004 21 42
10. J.H. Yoon, H. Higuchi, N.W. Werneburg, S.H. Kaufmann, and G.J. Gores Bile acids induce cyclooxygenase-2 expression via the epidermal growth factor receptor in a human cholangiocarcinoma cell line Gastroenterology 122 2002 985 993
11. J.H. Yoon, N.W. Werneburg, H. Higuchi, A.E. Canbay, S.H. Kaufmann, C. Akgul, S.W. Edwards, and G.J. Gores Bile acids inhibit Mcl-1 protein turnover via an epidermal growth factor receptor/Raf-1-dependent mechanism Cancer Res. 62 2002 6500 6505
12. G. Svegliati-Baroni, F. Ridolfi, R. Hannivoort, S. Saccomanno, M. Homan, S. De Minicis, P.L. Jansen, C. Candelaresi, A. Benedetti, and H. Moshage Bile acids induce hepatic stellate cell proliferation via activation of the epidermal growth factor receptor Gastroenterology 128 2005 1042 1055
13. M. Tsujii, and R.N. DuBois Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2 Cell 83 1995 493 501
14. M. Tsujii, S. Kawano, S. Tsuji, H. Sawaoka, M. Hori, and R.N. DuBois Cyclooxygenase regulates angiogenesis induced by colon cancer cells Cell 93 1998 705 716
15. M. Kondo, H. Yamamoto, H. Nagano, J. Okami, Y. Ito, J. Shimizu, H. Eguchi, A. Miyamoto, K. Dono, K. Umeshita, N. Matsuura, K. Wakasa, S. Nakamori, M. Sakon, and M. Monden Increased expression of COX-2 in nontumor liver tissue is associated with shorter disease-free survival in patients with hepatocellular carcinoma Clin. Cancer Res. 5 1999 4005 4012
16. H. Yamamoto, M. Kondo, S. Nakamori, H. Nagano, K. Wakasa, Y. Sugita, J. Chang-De, S. Kobayashi, B. Damdinsuren, K. Dono, K. Umeshita, M. Sekimoto, M. Sakon, N. Matsuura, and M. Monden JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis Gastroenterology 125 2003 556 571
17. D.A. Moulding, J.A. Quayle, C.A. Hart, and S.W. Edwards Mcl-1 expression in human neutrophils: regulation by cytokines and correlation with cell survival Blood 92 1998 2495 2502
18. T. Yang, K.M. Kozopas, and R.W. Craig The intracellular distribution and pattern of expression of Mcl-1 overlap with, but are not identical to, those of Bcl-2 J. Cell Biol. 128 1995 1173 1184
19. P. Zhou, L. Qian, K.M. Kozopas, and R.W. Craig Mcl-1, a Bcl-2 family member, delays the death of hematopoietic cells under a variety of apoptosis-inducing conditions Blood 89 1997 630 643
20. L. Xu, A.Y. Hui, E. Albanis, M.J. Arthur, S.M. O'Byrne, W.S. Blaner, P. Mukherjee, S.L. Friedman, and F.J. Eng Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis Gut 54 2005 142 151
21. G. Alpini, J.O. Phillips, B. Vroman, and N.F. LaRusso Recent advances in the isolation of liver cells Hepatology 20 1994 494 514
22. Y.S. Lim, K.A. Kim, J.O. Jung, J.H. Yoon, K.S. Suh, C.Y. Kim, and H.S. Lee Modulation of cytokeratin expression during in vitro cultivation of human hepatic stellate cells: evidence of transdifferentiation from epithelial to mesenchymal phenotype Histochem. Cell Biol. 118 2002 127 136
23. M. Taniai, A. Grambihler, H. Higuchi, N. Werneburg, S.F. Bronk, D.J. Farrugia, S.H. Kaufmann, and G.J. Gores Mcl-1 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in human cholangiocarcinoma cells Cancer Res. 64 2004 3517 3524
24. P. Kwo, T. Patel, S.F. Bronk, and G.J. Gores Nuclear serine protease activity contributes to bile acid-induced apoptosis in hepatocytes Am. J. Physiol. 268 1995 G613 G621
25. K.M. Kozopas, T. Yang, H.L. Buchan, P. Zhou, and R.W. Craig MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2 Proc. Natl. Acad. Sci. USA 90 1993 3516 3520
26. Y.S. Guo, M.R. Hellmich, X.D. Wen, and C.M. Townsend Jr. Activator protein-1 transcription factor mediates bombesin-stimulated cyclooxygenase-2 expression in intestinal epithelial cells J. Biol. Chem. 276 2001 22941 22947
27. M. Karin The regulation of AP-1 activity by mitogen-activated protein kinases J. Biol. Chem. 270 1995 16483 16486
28. A.J. Whitmarsh, and R.J. Davis Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways J. Mol. Med. 74 1996 589 607
29. S. Gupta, R.T. Stravitz, P. Dent, and P.B. Hylemon Down-regulation of cholesterol 7alpha-hydroxylase (CYP7A1) gene expression by bile acids in primary rat hepatocytes is mediated by the c-Jun N-terminal kinase pathway J. Biol. Chem. 276 2001 15816 15822
30. A. Ristimaki, K. Narko, and T. Hla Down-regulation of cytokine-induced cyclo-oxygenase-2 transcript isoforms by dexamethasone: evidence for post-transcriptional regulation Biochem. J. 318 Pt. 1 1996 325 331
31. A. Jacobson, and S.W. Peltz Interrelationships of the pathways of mRNA decay and translation in eukaryotic cells Annu. Rev. Biochem. 65 1996 693 739
32. J.H. Yoon, A.E. Canbay, N.W. Werneburg, S.P. Lee, and G.J. Gores Oxysterols induce cyclooxygenase-2 expression in cholangiocytes: implications for biliary tract carcinogenesis Hepatology 39 2004 732 738
33. Y.P. Rao, E.J. Studer, R.T. Stravitz, S. Gupta, L. Qiao, P. Dent, and P.B. Hylemon Activation of the Raf-1/MEK/ERK cascade by bile acids occurs via the epidermal growth factor receptor in primary rat hepatocytes Hepatology 35 2002 307 314
34. R. Marais, Y. Light, H.F. Paterson, and C.J. Marshall Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation EMBO J. 14 1995 3136 3145